3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
6
Pancreatic Neoplasms
5
Neoplasms
2
Lung Neoplasms
2
Head and Neck Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Rhabdoid Tumor
1
Papillary renal cell carcinoma, sporadic
1
Oropharyngeal Neoplasms
1
Neoplasms, Squamous Cell
1
Neoplasms, Basal Cell
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Mouth Neoplasms
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer
1
Liver Cirrhosis
1
Laryngeal Neoplasms
1
Kidney Neoplasms
1
Hypopharyngeal Neoplasms
1
Hereditary leiomyomatosis and renal cell cancer
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Choroid Plexus Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Carcinoma
1
Breast Neoplasms
1
Interventions
Cyclophosphamide
48
fludarabine
32
Methotrexate
26
blinatumomab
20
Dexamethasone
20
fludarabine phosphate
19
Vincristine
19
Whole-Body Irradiation
17
Specimen Handling
17
Cytarabine
17
Tacrolimus
15
Peripheral Blood Stem Cell Transplantation
14
Mycophenolic Acid
14
Melphalan
13
Calcium Dobesilate
12
Busulfan
12
Biopsy
12
merphos
11
Mercaptopurine
11
Stem Cell Transplantation
10
Granulocyte Colony-Stimulating Factor
10
Etoposide
10
Cyclosporine
10
Thiotepa
9
Rituximab
9
Magnetic Resonance Spectroscopy
9
Doxorubicin
9
venetoclax
8
ponatinib
8
dexamethasone acetate
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Erlotinib Hydrochloride
×
90 days
×
Clear all
No trials found.